Skip to main content
Home

Breadcrumb

  1. Coronavirus
  2. Cannabis
  3. Cannabis for medical purposes
  4. Revision of the Narcotics Act

Revision of the Narcotics Act

All questions on this topic
How will the effects of the revised Act be monitored in Switzerland?
Why was a revision of the Act needed?
What is being done to prevent abuse in connection with the lifting of the ban on cannabis for medical purposes?
As regards medicinal cannabis products, what has changed with the revision of the Act?
FAQ Software by 10+

Navigation

  • Chemical Precautionary Matrix
    • Area of Application for Materials
    • Areas of Application of the Precautionary Matrix
    • Environmental Section
    • Explanation of Terms
    • Fill out
    • General
    • Handling of Nanomaterials
    • Interpretation
    • Measures and use
    • Scope of Application
  • Hirntumoren bei Kindern
  • National Vaccination Strategy (NVS)
  • Strahlenschutz
    • Patientensicherheit im Strahlenschutz
  • Supply of medicines
  • Krankenversicherung
  • Ambulant vor Stationär
  • Neuregelung psychologische Psychotherapie
  • Gesetzgebung Krebsregistrierung
  • CFQ
    • Strategie und Ziele
    • Finanzierung und Reglement
    • Formulaire de demande
    • Beurteilung der Gesuche
  • Cannabis
    • Cannabis for medical purposes
  • Covid-19-Impfung Gesundheitsfachpersonen
    • Wirksamkeit
    • Administratives / Regelstruktur
    • Durchführung
    • Unerwünschte Impferscheinungen
  • Coronavirus
    • Infection and risks
    • COVID certificate
    • Vaccination
    • Masks
    • Pregnancy

Language:

  • English
  • Deutsch
  • Italian
  • Français
Home

Footer

  • made in ?? by zehnplus